Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Chengyou Du
Observed names:
C DU,
C Du,
C Y Du,
C. Du,
Cheng-You DU,
Cheng-You Du,
Cheng‐You Du,
Chenyou Du,
Du Chengyou
show all 9
Institutions:
The Affiliated Yongchuan Hospital of Chongqing Medical University,
Chongqing Medical University
Observed institutions:
Chongqing University,
The Affiliated Yongchuan Hospital of Chongqing Medical University,
Chongqing Medical University
ORCID:
0000-0003-1977-6362
Observed ORCIDs:
0000-0003-1977-6362,
0000-0001-7561-6318
OpenAlex ID:
A5101612588
Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study
2021
·
Zhenggang Ren
, Jianming Xu
, et al.
·
The Lancet Oncology
·
1,230
A systematic review of robotic-assisted liver resection and meta-analysis of robotic versus laparoscopic hepatectomy for hepatic neoplasms
2015
·
Jianguo Qiu
, Shuting Chen
, et al.
·
Surgical Endoscopy
·
126
TAZ regulates cell proliferation and epithelial–mesenchymal transition of human hepatocellular carcinoma
2014
·
Heng Xiao
, Ning Jiang
, et al.
·
Cancer Science
·
95
PDF
Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trial
2025
·
Yinghong Shi
, Guohong Han
, et al.
·
The Lancet. Gastroenterology & hepatology
·
67
Hepatic stellate cell exosome-derived circWDR25 promotes the progression of hepatocellular carcinoma via the miRNA-4474-3P-ALOX-15 and EMT axes
2022
·
Lei Liu
, Rui Liao
, et al.
·
BioScience Trends
·
46
PDF
Systemic and intratumoral balances between monocytes/macrophages and lymphocytes predict prognosis in hepatocellular carcinoma patients after surgery
2016
·
Rui Liao
, Ning Jiang
, et al.
·
Oncotarget
·
46
GBP2 as a potential prognostic biomarker in pancreatic adenocarcinoma
2021
·
Bo Liu
, Rongfei Huang
, et al.
·
PeerJ
·
35
Combined Preoperative ALBI and FIB-4 Is Associated with Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy
2018
·
Rui Liao
, De-Wei Li
, et al.
·
Journal of Gastrointestinal Surgery
·
35
Preoperative neutrophil-to-lymphocyte ratio predicts recurrence of patients with single-nodule small hepatocellular carcinoma following curative resection: a retrospective report
2015
·
Rui Liao
, Zhuo-Wei Tang
, et al.
·
World Journal of Surgical Oncology
·
34
PDF
LBA2 Sintilimab plus bevacizumab biosimilar vs sorafenib as first-line treatment for advanced hepatocellular carcinoma (ORIENT-32)2
2020
·
Z. Ren
, J. Fan
, et al.
·
Annals of Oncology
·
32
Reprogramming Exosomes to Escape from Immune Surveillance for Mitochondrial Protection in Hepatic Ischemia-Reperfusion Injury
2023
·
Shanshan Liu
, Xinyu Xiao
, et al.
·
Theranostics
·
29
PDF
Increased Surgical Complications but Improved Overall Survival with Adult Living Donor Compared to Deceased Donor Liver Transplantation: A Systematic Review and Meta‐Analysis
2020
·
Wei Tang
, Jian-Guo Qiu
, et al.
·
BioMed Research International
·
29
PDF
Comparison and validation of the prognostic value of preoperative systemic immune cells in hepatocellular carcinoma after curative hepatectomy
2018
·
Rui Liao
, Cong Peng
, et al.
·
Cancer Medicine
·
29
PDF
ERK pathway activation contributes to the tumor-promoting effects of hepatic stellate cells in hepatocellular carcinoma
2017
·
Yu-Xiao Xie
, Rui Liao
, et al.
·
Immunology Letters
·
27
Immune Checkpoint Inhibitors in Patients with Recurrent Hepatocellular Carcinoma after Liver Transplantation: A Case Report and Literature Review
2020
·
Jianguo Qiu
, Wei Tang
, et al.
·
Current Cancer Drug Targets
·
25
An imbalance between stellate cells and γδT cells contributes to hepatocellular carcinoma aggressiveness and recurrence
2019
·
Bao-Yong Zhou
, Jun-Hua Gong
, et al.
·
Hepatology International
·
25
Metavir and FIB-4 scores are associated with patient prognosis after curative hepatectomy in hepatitis B virus-related hepatocellular carcinoma: a retrospective cohort study at two centers in China
2016
·
Rui Liao
, Yi-Peng Fu
, et al.
·
Oncotarget
·
25
PDF
Chinese Expert Consensus on Immunotherapy for Hepatocellular Carcinoma (2021 Edition)
2022
·
Yu Yang
, Juxian Sun
, et al.
·
Liver Cancer
·
24
PDF
Prognostic value of tertiary lymphoid structures in hepatocellular carcinoma: a meta-analysis and systematic review
2024
·
Lingbo Hu
, Xuemei Li
, et al.
·
Frontiers in Immunology
·
23
The prognostic value of a classification system for centrally located liver tumors in the setting of hepatocellular carcinoma after mesohepatectomy
2016
·
Jianguo Qiu
, Shuting Chen
, et al.
·
Surgical Oncology
·
23
Antecolic reconstruction is associated with a lower incidence of delayed gastric emptying compared to retrocolic technique after Whipple or pylorus-preserving pancreaticoduodenectomy
2019
·
Jianguo Qiu
, Ming Li
, et al.
·
Medicine
·
22
Toripalimab Plus Bevacizumab as First-line Treatment for Advanced Hepatocellular Carcinoma: A Prospective, Multicenter, Single-Arm, Phase II Trial
2024
·
Yajin Chen
, Chengyou Du
, et al.
·
Clinical Cancer Research
·
20
Minimally invasive versus open radical resection surgery for hilar cholangiocarcinoma: Comparable outcomes associated with advantages of minimal invasiveness
2021
·
Wei Tang
, Jian-Guo Qiu
, et al.
·
PLoS ONE
·
20
PDF
Construction of a five-gene prognostic model based on immune-related genes for the prediction of survival in pancreatic cancer
2021
·
Bo Liu
, Tingting Fu
, et al.
·
Bioscience Reports
·
19
Augmenter of liver regeneration promotes hepatic regeneration depending on the integrity of Kupffer cell in rat small-for-size liver transplantation
2013
·
Kang Yang
, Chengyou Du
, et al.
·
Journal of Surgical Research
·
18
Show more works
View as search
Works count:
101
Citation count:
2,402
H-index:
21
I10-index:
39
Year
Topic
Type